Gene · 51330
Papers2,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Endoplasmic Reticulum Stress-Related Genes in Cartilage Defects: Implications for Diagnosis and Therapy. | Comb Chem High Throughput Screen | 2026 | 41239927 | PubTator, text mining | PubMed |
| TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndrome. | Front Immunol | 2025 | 41994499 | PubTator, text mining | PubMed |
| Mechanism of action of Butein in cutaneous squamous cell carcinoma through regulation of the TWEAK-FN14 signaling pathway. | Front Oncol | 2025 | 41458609 | PubTator, text mining | PubMed |
| Control of quiescence and activation of human muscle stem cells by cytokines. | PLoS One | 2025 | 41348866 | PubTator, text mining | PubMed |
| METTL14 Regulates the Expression of Genes Related to Interferon, Interleukin and MHC Class I in Nasopharyngeal Carcinoma Cells. | Cancer Med | 2025 | 41316520 | PubTator, text mining | PubMed |
| Over-Expression of TNFRSF12A Promotes Immune Suppression and Facilitates Angiogenesis in Triple-Negative Breast Cancer. | Biology (Basel) | 2025 | 41300305 | PubTator, text mining | PubMed |
| Development of a PANoptosis-Related Pathomics Prognostic Model in Ovarian Cancer: A Multi-Omics Study. | J Cell Mol Med | 2025 | 41284376 | PubTator, text mining | PubMed |
| Neoadjuvant chemotherapy modulates mast cell phenotypes and immune infiltration in high-grade serous carcinoma. | Gynecol Oncol | 2025 | 41176887 | PubTator, text mining | PubMed |
| Targeting TWEAK/Fn14 pathway: Implications for stem cell regulation and advancements in skin disease therapies. | Int Immunopharmacol | 2025 | 41138306 | PubTator, text mining | PubMed |
| Detection of Anaphylaxis Through the Cutaneous Barrier. | Curr Allergy Asthma Rep | 2025 | 41016999 | PubTator, text mining | PubMed |
| Integrative assessment of RNA sequencing and in silico analysis to pinpoint mRNAs, lncRNAs, and circRNAs interactions with miRNAs underlying arsenic-induced neurotoxicity. | BMC Genomics | 2025 | 40999364 | PubTator, text mining | PubMed |
| A Systematic Review on the Role of the Stria Vascularis in Menière's Disease Pathogenesis. | J Assoc Res Otolaryngol | 2025 | 40987969 | PubTator, text mining | PubMed |
| Isorhamnetin attenuates renal interstitial fibrosis by targeting TWEAK/Fn14-mediated epithelial-mesenchymal transition. | Front Immunol | 2025 | 40977693 | PubTator, text mining | PubMed |
| LIGHT in combination with IL-13 or IL-17 drives inflammatory transcriptional signatures in human pulmonary fibroblasts relevant for human lung disease. | Immunohorizons | 2025 | 40972652 | PubTator, text mining | PubMed |
| Low Potassium Triggers Tubular Epithelial NLR Family Pyrin Domain-Containing 3/Apoptosis-Associated Speck-Like Protein-Containing a CARD-Driven Kidney Inflammation Independently of Inflammasomes. | Am J Pathol | 2025 | 40946795 | PubTator, text mining | PubMed |
| Identifying novel therapeutic targets for non-alcoholic fatty liver disease using bioinformatics approaches: from drug repositioning to traditional Chinese medicine. | Front Bioinform | 2025 | 40932836 | PubTator, text mining | PubMed |
| Epigenetic and Genotoxic Mechanisms of PFAS-Induced Neurotoxicity: A Molecular and Transgenerational Perspective. | Toxics | 2025 | 40863905 | PubTator, text mining | PubMed |
| Inflammatory factor CCL2 enhances the interaction between monocyte-macrophage cells and liver parenchymal cells to promote liver inflammation and fibrosis in biliary atresia. | BMC Pediatr | 2025 | 40849451 | PubTator, text mining | PubMed |
| The role of m5C, m1A and m7G modifications in tumors of urinary system. | Front Cell Dev Biol | 2025 | 40809690 | PubTator, text mining | PubMed |
| Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease. | Cells | 2025 | 40801635 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51330/papers?page=4